Iron oxide nanoparticles for biomedical applications: a perspective on synthesis, drugs, antimicrobial activity, and toxicity
Medical applications and biotechnological advances, including magnetic resonance
imaging, cell separation and detection, tissue repair, magnetic hyperthermia and drug …
imaging, cell separation and detection, tissue repair, magnetic hyperthermia and drug …
[HTML][HTML] Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain
Magnetic nanoparticles in general, and iron oxide nanoparticles in particular, have been
studied extensively during the past 20 years for numerous biomedical applications. The …
studied extensively during the past 20 years for numerous biomedical applications. The …
Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans
Hyperthermia therapy (HT) is the exposure of a region of the body to elevated temperatures
to achieve a therapeutic effect. HT anticancer properties and its potential as a cancer …
to achieve a therapeutic effect. HT anticancer properties and its potential as a cancer …
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles
E da Silva Santos, KAB Nogueira… - International journal of …, 2021 - Elsevier
The epidermal growth factor receptor (EGFR) belongs to the tyrosine kinase receptors family
and is present in the epithelial cell membrane. Its endogenous activation occurs through the …
and is present in the epithelial cell membrane. Its endogenous activation occurs through the …
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy
Glioblastoma (GBM), the most aggressive form of brain cancer, has witnessed very little
clinical progress over the last decades, in part, due to the absence of effective drug delivery …
clinical progress over the last decades, in part, due to the absence of effective drug delivery …
Key for crossing the BBB with nanoparticles: The rational design
SM Lombardo, M Schneider, AE Türeli… - Beilstein journal of …, 2020 - beilstein-journals.org
Central nervous system diseases are a heavy burden on society and health care systems.
Hence, the delivery of drugs to the brain has gained more and more interest. The brain is …
Hence, the delivery of drugs to the brain has gained more and more interest. The brain is …
Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment
Glioblastoma (GBM) is one of the most aggressive and deadliest central nervous system
tumors, and the current standard treatment is surgery followed by radiotherapy with …
tumors, and the current standard treatment is surgery followed by radiotherapy with …
Nanotechnology and nanocarrier-based drug delivery as the potential therapeutic strategy for glioblastoma multiforme: An update
JF Hsu, SM Chu, CC Liao, CJ Wang, YS Wang, MY Lai… - Cancers, 2021 - mdpi.com
Simple Summary Glioblastoma multiforme (GBM) are among the most lethal tumors. The
highly invasive nature and presence of GBM stem cells, as well as the blood brain barrier …
highly invasive nature and presence of GBM stem cells, as well as the blood brain barrier …
Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies
A Jahangiri, AT Chin, PM Flanigan, R Chen… - Journal of …, 2017 - thejns.org
Glioblastoma is the most common malignant brain tumor, and it carries an extremely poor
prognosis. Attempts to develop targeted therapies have been hindered because the blood …
prognosis. Attempts to develop targeted therapies have been hindered because the blood …
Hyperthermia treatment advances for brain tumors
GP Skandalakis, DR Rivera, CD Rizea… - International Journal …, 2020 - Taylor & Francis
Hyperthermia therapy (HT) of cancer is a well-known treatment approach. With the advent of
new technologies, HT approaches are now important for the treatment of brain tumors. We …
new technologies, HT approaches are now important for the treatment of brain tumors. We …